Avicanna Inc.
Avicanna Inc. (AVCN.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVCN.TO · as of Jun 8, 2026
Key Statistics
Explore Avicanna Inc. Data
avcn.to stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
avcn.to competitorsAVCN.TO
BUX.CN
CWEB.TO
GLAB.CN
GWAY.CN
IZO.CNStock Performance
Full HistoryAbout Avicanna Inc.
Avicanna Inc. a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company …
what is avicanna inc. · avcn.to stock overview · avicanna inc. company profile · who is avicanna inc. ceo · avcn.to TSX · avicanna inc. headquarters · avicanna inc. business segments
About Stock Overview & Key Data
Avicanna Inc. (AVCN.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Jul 18, 2019. As of the latest trading session, AVCN.TO stock price is $0.12, with a market capitalization of $14.5M. The stock has returned -55.77% over the past 12 months and -48.89% year-to-date.
In fiscal year 2025, Avicanna Inc. reported revenue of $25.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Avicanna Inc. (AVCN.TO) stock price is $0.12. The stock is traded on TSX under the ticker symbol AVCN.TO. The 52-week range is $0.11 – $0.31.